Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

A Dutch guideline for the use of clozapine.

Schulte PF, Cohen D, Bogers JP, van Dijk D, Bakker B.

Aust N Z J Psychiatry. 2010 Nov;44(11):1055-6. doi: 10.3109/00048674.2010.514859. No abstract available.

PMID:
21034191
2.

Clozapine alone versus clozapine and risperidone for refractory schizophrenia.

Gerson SL.

N Engl J Med. 2006 Apr 27;354(17):1846-8; author reply 1846-8. No abstract available.

PMID:
16642587
3.

Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.

van de Loosdrecht AA, Faber HJ, Hordijk P, Uges DR, Smit A.

Neth J Med. 1998 Jan;52(1):26-9.

PMID:
9573739
4.

Lithium and clozapine-induced neutropenia/agranulocytosis.

Blier P, Slater S, Measham T, Koch M, Wiviott G.

Int Clin Psychopharmacol. 1998 May;13(3):137-40.

PMID:
9690982
5.

Reversible neutropenia with olanzapine following clozapine-induced neutropenia.

Thangadurai P, Jyothi KS, Gopalakrishnan R, Kuruvilla A, Jacob KS.

Am J Psychiatry. 2006 Jul;163(7):1298. No abstract available.

PMID:
16816247
6.

Update on clozapine.

[No authors listed]

Med Lett Drugs Ther. 1993 Feb 19;35(890):16-8. No abstract available.

PMID:
8093972
7.

[A case study; ethnicity and clozapine, a risky combination?].

Laan WJ, Ramlal D.

Tijdschr Psychiatr. 2012;54(9):829-33. Dutch.

8.

Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients.

McAllister CG, Rapaport MH, Pickar D, Paul SM.

Arch Gen Psychiatry. 1989 Oct;46(10):956-7. No abstract available.

PMID:
2572208
9.

Agranulocytosis and neutropenia with typical and atypical neuroleptics.

Hong X, Wang X.

Am J Psychiatry. 2001 Oct;158(10):1736-7. No abstract available.

PMID:
11579015
10.

Use of cytokines in clozapine-induced agranulocytosis.

Chin-Yee I, Bezchlibnyk-Butler K, Wong L.

Can J Psychiatry. 1996 Jun;41(5):280-4. Review.

PMID:
8793147
11.

[Clozapine screening: white bloodcell counts no longer sufficient].

Cohen D; Clozapinepluswerkgroep.

Tijdschr Psychiatr. 2010;52(11):785-90. Dutch.

12.

[Reversible clozapine-induced agranulocytosis].

Nery-Fernandes F, Silveira VP, Quarantini LC, Coutinho DM, Scippa AM.

Rev Bras Psiquiatr. 2006 Jun;28(2):162. Epub 2006 Jun 26. Portuguese. No abstract available.

13.

Clozapine treatment after agranulocytosis induced by classic neuroleptics.

Bauer M, Mackert A.

J Clin Psychopharmacol. 1994 Feb;14(1):71-3.

PMID:
7908676
14.

Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients.

Swartz JR, Ananth J, Smith MW, Burgoyne KS, Gadasally R, Arai Y.

J Clin Psychiatry. 1999 Feb;60(2):119-21.

PMID:
10084639
15.

Clozapine: the commitment to patient safety.

Alphs LD, Anand R.

J Clin Psychiatry. 1999;60 Suppl 12:39-42. Review.

16.

Should the clozapine protocol be obeyed?

Drew L.

Aust N Z J Psychiatry. 2011 Sep;45(9):790. doi: 10.3109/00048674.2011.587398. Epub 2011 Jun 13. No abstract available.

PMID:
21668297
17.

Clozapine--should race affect prescribing guidelines?

Mallinger JB, Lamberti JS.

Schizophr Res. 2006 Mar;83(1):107-8. Epub 2006 Mar 7. No abstract available.

PMID:
16520022
18.

[Introduce a new regime for blood tests in clozapine treatment].

Olsson H, Lennestål R, Hägg S.

Lakartidningen. 2015 Oct 20;112. pii: DRCR. Swedish. No abstract available.

PMID:
26485134
19.

Pharmacologic advances in the treatment of schizophrenia.

Keith SJ.

N Engl J Med. 1997 Sep 18;337(12):851-2. No abstract available.

PMID:
9295245
20.

[Patient knowledge regarding Clozapine-induced agranulocytosis].

Haberfellner EM, Rittmannsberger H.

Psychiatr Prax. 2006 May;33(4):194-6. German. No abstract available.

PMID:
16680627
Items per page

Supplemental Content

Write to the Help Desk